Indian generic drugs generated a revenue of around 21 billion U.S. dollars in the prescribed drug market in 2015. This was expected to go up to approximately 28 billion dollars by 2020, indicating a strong competence and growth in this drug segment. Overall, generic drugs had about 70 percent of market share in terms of revenue for India's pharmaceutical sector in 2019.
Revenue of generic drugs in the prescribed drug market in India from 2008 to 2015 with a forecast for 2020 (in billion U.S. dollars)
Basic Account
Get to know the platform
You only have access to basic statistics.
This statistic is not included in your account.
Starter Account
The ideal entry-level account for individual users
- Instant access to 1m statistics
- Download in XLS, PDF & PNG format
- Detailed references
$199 USD / Month *
Professional Account
Full access
Business Solutions including all features.
* Prices do not include sales tax.
Other statistics that may interest you Pharmaceutical industry in Norway
Overview
5
- Basic Statistic Number of pharmaceuticals available in Norway 2013-2021
- Basic Statistic Leading pharmaceutical companies in Norway 2021, by revenue
- Premium Statistic Leading pharmaceutical companies in Norway 2021, by market share
- Basic Statistic Largest nonprescription pharmaceutical companies in Norway 2021, by market share
- Basic Statistic Public expenditure on blue prescriptions in Norway 2012-2021
Pharmaceutical revenue
5
- Basic Statistic Pharmaceutical revenue in Norway 2012-2021
- Basic Statistic Market share of generic pharmaceuticals in Norway 2013-2021
- Basic Statistic Sales value of nonprescription pharmaceuticals in Norway 2017-2021
- Basic Statistic Sales of pharmaceuticals in Norway by ATC main group 2021
- Basic Statistic Sales volume pharmaceuticals in Norway by drug category 2022
Production and trade
4
- Basic Statistic producer price index of chemical and pharmaceutical products in Norway 2008-2023
- Basic Statistic Number of pharmaceutical preparation enterprises in Norway 2016-2022
- Basic Statistic Number of employees in pharmaceutical industry in Norway 2016-2022
- Basic Statistic Import and export value of basic pharmaceutical products in Norway 2009-2023
R&D, patents and new products
4
- Basic Statistic Number of applications for clinical trials in Norway 2008-2021
- Basic Statistic Number of applications for clinical trials in Norway 2008-2021, by type of actor
- Basic Statistic Number of new and expired active substances in Norway 2013-2021
- Basic Statistic Number of biotechnology patents in Norway 2011-2020
Further related statistics
10
- Pfizer's ad spending 2006-2023
- Number of employees at Sinopharm 2011-2022
- Annual revenue of Sinopharm 2010-2022
- AstraZeneca's revenue from top product Pulmicort 2006-2023
- AstraZeneca's expenditure on research and development 2006-2023
- CVS Health's total assets 2005-2023
- Walgreens gross profit and net earnings in the U.S. 2005-2023
- Foreign exchange earnings from tourism in India 2000-2022
- Number of international tourist arrivals in India 2010-2021
- International tourism receipts of India 2011-2022
Further Content: You might find this interesting as well
Statistics
- Pfizer's ad spending 2006-2023
- Number of employees at Sinopharm 2011-2022
- Annual revenue of Sinopharm 2010-2022
- AstraZeneca's revenue from top product Pulmicort 2006-2023
- AstraZeneca's expenditure on research and development 2006-2023
- CVS Health's total assets 2005-2023
- Walgreens gross profit and net earnings in the U.S. 2005-2023
- Foreign exchange earnings from tourism in India 2000-2022
- Number of international tourist arrivals in India 2010-2021
- International tourism receipts of India 2011-2022
India Brand Equity Foundation. (June 25, 2019). Revenue of generic drugs in the prescribed drug market in India from 2008 to 2015 with a forecast for 2020 (in billion U.S. dollars) [Graph]. In Statista. Retrieved June 10, 2024, from https://www.statista.com/statistics/712829/india-generic-drugs-revenue-in-prescribed-drug-market/
India Brand Equity Foundation. "Revenue of generic drugs in the prescribed drug market in India from 2008 to 2015 with a forecast for 2020 (in billion U.S. dollars)." Chart. June 25, 2019. Statista. Accessed June 10, 2024. https://www.statista.com/statistics/712829/india-generic-drugs-revenue-in-prescribed-drug-market/
India Brand Equity Foundation. (2019). Revenue of generic drugs in the prescribed drug market in India from 2008 to 2015 with a forecast for 2020 (in billion U.S. dollars). Statista. Statista Inc.. Accessed: June 10, 2024. https://www.statista.com/statistics/712829/india-generic-drugs-revenue-in-prescribed-drug-market/
India Brand Equity Foundation. "Revenue of Generic Drugs in The Prescribed Drug Market in India from 2008 to 2015 with a Forecast for 2020 (in Billion U.S. Dollars)." Statista, Statista Inc., 25 Jun 2019, https://www.statista.com/statistics/712829/india-generic-drugs-revenue-in-prescribed-drug-market/
India Brand Equity Foundation, Revenue of generic drugs in the prescribed drug market in India from 2008 to 2015 with a forecast for 2020 (in billion U.S. dollars) Statista, https://www.statista.com/statistics/712829/india-generic-drugs-revenue-in-prescribed-drug-market/ (last visited June 10, 2024)
Revenue of generic drugs in the prescribed drug market in India from 2008 to 2015 with a forecast for 2020 (in billion U.S. dollars) [Graph], India Brand Equity Foundation, June 25, 2019. [Online]. Available: https://www.statista.com/statistics/712829/india-generic-drugs-revenue-in-prescribed-drug-market/